SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (131)8/30/2000 2:39:47 AM
From: scaram(o)uche  Read Replies (1) | Respond to of 724
 
Message 14282792

PB post relating to the magnitude of potential "trickle down"......

http://www.signalsmag.com/signalsmag.nsf/0/BD3C00680F4D2D108...

the first seven months of 2000, total public offerings reaped about $9.3 billion, with IPOs pulling in close to $4.4 billion of that.

These five IPOs (Evotec, Symyx, Tularik, Caliper, Maxygen) started the biggest public financing wave that the biotechnology sector has ever witnessed

Etc.